Novo Nordisk A/S vs Peloton Interactive Inc — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Peloton Interactive Inc trades at $6.35 (market cap $2.82B). The key difference: Novo Nordisk A/S is far larger — about 78.2× Peloton Interactive Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Peloton Interactive Inc pays none. Which is the better fit depends on your goals.
| NVO | PTON | |
|---|---|---|
Market Cap | $220.53B | $2.82B |
Sector | Health | Consumer Cyclical |
52-Week High | $71.70 | $9.00 |
52-Week Low | $35.29 | $3.71 |
Enterprise Value | $239.49B | $3.42B |
Dividend Yield | 3.63% | — |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →